Free Trial

Predictive Oncology (POAI) Earnings Date, Estimates & Call Transcripts

Predictive Oncology logo
$0.98 0.00 (-0.40%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.95 -0.03 (-2.57%)
As of 05/23/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Predictive Oncology Earnings Summary

Predictive Oncology posted Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.32, which missed the consensus estimate of -$0.09 by $0.23. Quarterly revenue was reported to be $0.11 million, below analysts' expectations of $1.50 million. With a trailing EPS of -$3.05, Predictive Oncology's earnings are expected to grow next year, from ($2.08) to ($0.13) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 14)
-$0.09
Actual EPS
(May. 14)
-$0.32 Missed By -$0.23
Actual Revenue
(May. 14)
$0.11M

Q1 2025 Earnings Resources

POAI Upcoming Earnings

Predictive Oncology's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Get Predictive Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Predictive Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

POAI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

POAI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Predictive Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.10-$0.10-$0.10
Q2 20251-$0.09-$0.09-$0.09
Q3 20251-$0.10-$0.10-$0.10
Q4 20251$0.06$0.06$0.06

Predictive Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/14/2025Q1 2025-$0.09-$0.32 -$0.23-$0.34$1.50M$0.11M
8/13/2024Q2 2024--$0.68 -$0.68-$0.68-$0.28M
5/14/2024Q1 2024--$1.04 -$1.04-$1.04-$0.42M
3/28/2024Q4 2023--$0.85 -$0.85-$0.85-$0.34M
11/13/2023Q3 2023--$0.78 -$0.78-$0.78-$0.72M
8/10/2023Q2 2023--$0.95 -$0.95-$0.92-$0.49M

Predictive Oncology Earnings - Frequently Asked Questions

Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on POAI's earnings history.

In the previous quarter, Predictive Oncology (NASDAQ:POAI) missed the analysts' consensus estimate of ($0.09) by $0.23 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. POAI's actual earnings.

Predictive Oncology (NASDAQ:POAI) has a recorded annual revenue of $1.73 million.

Predictive Oncology (NASDAQ:POAI) has a recorded net income of -$13.98 million. POAI has generated -$3.05 earnings per share over the last four quarters.

Predictive Oncology's earnings are expected to grow from ($2.08) per share to ($0.13) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:POAI) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners